GlassScriptPhysician profile
Katherine B Simerson
NPI 1740722479
$2,558.48
in general payments reported to CMS, 2019-2025
19 companies · $637 in 2025
The $637 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $250 · 2022: $296 · 2023: $497 · 2024: $879 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,011.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $481.63 | 2021-2025 | Zerbaxa, Dificid, Recarbrio |
| Pfizer INC. | $462.31 | 2021-2025 | |
| Abbvie INC. | $240.54 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $207.63 | 2022-2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $207.40 | 2021-2025 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Novartis Pharmaceuticals Corporation | $166.06 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $145.77 | 2021-2024 | Lokelma, Farxiga |
| Janssen Pharmaceuticals, INC | $111.68 | 2021-2024 | Xarelto |
| Boston Scientific Corporation | $106.06 | 2021-2024 | Watchman Flx |
| Alexion Pharmaceuticals, INC. | $91.59 | 2021-2024 | Ultomiris |
| Paratek Pharmaceuticals, INC. | $72.20 | 2022 | |
| Sk Life Science, INC. | $59.81 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $54.87 | 2022-2023 | Camzyos |
| Novo Nordisk INC | $51.54 | 2023-2024 | Ozempic, Rybelsus |
| Electromed, INC. | $27.19 | 2023 | Smartvest |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioxcel Therapeutics, INC. | $23.10 | 2023 | Igalmi |
| Bayer Healthcare Pharmaceuticals INC. | $21.20 | 2024 | |
| Philips North America LLC | $14.29 | 2022 | |
| Melinta Therapeutics, LLC | $13.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Simerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.